NCT00170729View on ClinicalTrials.gov

A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery

PHASE4CompletedINTERVENTIONAL

Enrollment

62

Participants

Timeline

Start Date

August 17, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

Cataract Surgery

Interventions

DRUG

Prednisolone acetate

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY

NCT00170729 - A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery | Biotech Hunter | Biotech Hunter